COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01733862
Recruitment Status : Completed
First Posted : November 27, 2012
Last Update Posted : May 30, 2019
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This study aims at assessing the impact of RV vaccination in hospitals in Nagoya City (administrative district), Japan, where RV vaccines have been introduced since November 2011 and financial support for vaccination costs by Nagoya city, Japan have been implemented from October 2012.

Condition or disease Intervention/treatment
Infections, Rotavirus Rotavirus Vaccines Other: Data collection

Detailed Description:

The electronic admission database or any other applicable database of the hospital will be reviewed to identify hospitalized children/children with outpatient visits/emergency room visits, less than five years of age who had been diagnosed with acute gastroenteritis (AGE) or RV GE either by the International Classification of Diseases and Related Health Problems 10th Revision (ICD 10) diagnostic code (AA00-AA09 for intestinal infectious diseases and A08.0 for RV specific GE) or by RV positive rapid diagnosis kit results.

Note: The outcomes for the outpatient and emergency room visits will be assessed only in case the data for outpatient and emergency room visits can be obtained from at least one of the study centers.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 5394 participants
Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: A Study to Assess the Impact of Rotavirus Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis (RV GE) in Japan
Actual Study Start Date : November 27, 2012
Actual Primary Completion Date : February 8, 2017
Actual Study Completion Date : February 8, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Gastroenteritis

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Group Japan
Children less than five years of age, hospitalized for RV GE or AGE and children with outpatient or emergency room visits for RV GE or AGE, between November 2007 and October 2016 (i.e., before and after the introduction of RV vaccination in Japan) in any of the selected hospitals.
 Other: Data collection

Data sheet. Data will be collected and is planned to be analysed at the following time points:

Pre-vaccination period: Nov 2007 to Oct 2011, transition period: Nov 2011 to Oct 2012 and post vaccination period: Nov 2012 to Oct 2016.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Occurrence of RV GE hospitalizations among all hospitalized children aged less than five years. [ Time Frame: From Nov 2007 to Oct 2016 ]

Secondary Outcome Measures :
  1. Occurrence of RV GE hospitalizations among AGE hospitalizations in children less than five years of age. [ Time Frame: From Nov 2007 to Oct 2016 ]
  2. Occurrence of RV GE hospitalizations by age group in children less than five years of age. [ Time Frame: From Nov 2007 to Oct 2016 ]
  3. Occurrence of AGE hospitalizations among all hospitalized children aged less than five years. [ Time Frame: From Nov 2007 to Oct 2016 ]
  4. Occurrence of outpatient visits for AGE among all outpatient visits in children less than five years of age. [ Time Frame: From Nov 2007 to Oct 2016 ]
  5. Occurrence of outpatient visits for RV GE among all outpatient visits in children less than five years of age. [ Time Frame: From Nov 2007 to Oct 2016 ]
  6. Occurrence of outpatient visits for RV GE among AGE outpatient visits in children less than five years of age. [ Time Frame: From Nov 2007 to Oct 2016 ]
  7. Duration of hospitalizations for RV GE or AGE, overall, for each year, season in children less than five years of age. [ Time Frame: From Nov 2007 to Oct 2016 ]
  8. Occurrence of hospitalizations for RV GE among all emergency visits for RV GE in children less than five years of age. [ Time Frame: From Nov 2007 to Oct 2016 ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 1824 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The study population will include children less than five years of age, hospitalized for RV GE or AGE and children with outpatient or emergency room visits for RV GE or AGE, between November 2007 and October 2016 (i.e., before and after the introduction of RV vaccination in Japan) in any of the selected hospitals.
Criteria

Inclusion Criteria:

- Children aged less than five years visiting hospitals for RV GE or AGE from 2007 to 2016, who live in the study area.

Exclusion Criteria:

- Not applicable.

Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01733862


Locations
Layout table for location information
Japan
GSK Investigational Site
Aichi, Japan, 457-8510
GSK Investigational Site
Aichi, Japan, 457-8511
GSK Investigational Site
Aichi, Japan, 457-85
GSK Investigational Site
Aichi, Japan, 466-8650
GSK Investigational Site
Aichi, Japan, 466-86
GSK Investigational Site
Aichi, Japan, 468-8520
GSK Investigational Site
Aichi, Japan, 468-85
Sponsors and Collaborators
GlaxoSmithKline
Investigators
Layout table for investigator information
Study Director: GSK Clinical Trials GlaxoSmithKline
Study Director: GSK Clinical Trials GlaxoSmithKline (for GlaxoSmithKline; Human Genome Sciences Inc., a GSK Company; Sirtris, a GSK Company; Stiefel, a GSK Company; ViiV Healthcare)
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:

Layout table for additonal information
Responsible Party: GlaxoSmithKline
ClinicalTrials.gov Identifier: NCT01733862    
Other Study ID Numbers: 116929
First Posted: November 27, 2012    Key Record Dates
Last Update Posted: May 30, 2019
Last Verified: May 2019
Keywords provided by GlaxoSmithKline:
Impact
Vaccination
Hospitalizations
Rotavirus gastroenteritis
Japan
Additional relevant MeSH terms:
Layout table for MeSH terms
Rotavirus Infections
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
 Reoviridae Infections
RNA Virus Infections
Virus Diseases